Latest Breaking News On - Tiago reis marques - Page 2 : comparemela.com

Pasithea Therapeutics Announces Results from 2023 Annual Meeting

Pasithea Therapeutics Announces Results from 2023 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTiago reis marquesLarry steinmanSimon dumesnilEmer leahyAlfred novakExchange commissionAlliance advisorsWhile the companyPasithea therapeutics corpPatrick gaynescorporate communicationsApproved proposalsPasithea therapeuticsIncentive planCurrent reportAnnual meeting

Pasithea Therapeutics Announces Results from 2023 Annual

Disclosure related to the annual meeting of Pasithea Therapeutics (Nasdaq: KTTA).

United statesLarry steinmanSimon dumesnilPatrick gaynesEmer leahyTiago reis marquesAlfred novakExchange commissionWhile the companyCorporate communicationsAlliance advisorsPasithea therapeutics corpApproved proposalsPasithea therapeuticsIncentive planCurrent report

Pasithea Therapeutics (KTTA) Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development

Pasithea Therapeutics (KTTA) Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tiago reis marquesPasithea therapeutics corpDrug administrationCentral nervous systemInvestigational new drug applicationChief executive officer

Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development

Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPatrick gaynesTiago reis marquesPasithea therapeutics corpCorporate communicationsExchange commissionWhile the companyDrug administrationCentral nervous systemInvestigational new drug applicationChief executive officerSolid tumorsAmyotrophic lateral sclerosisPrivate securities litigation reform actAnnual reportQuarterly report

Pasithea Therapeutics (KTTA) Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets α5β1 Integrin for the Treatment of both Sporadic and Familial ALS

Pasithea Therapeutics (KTTA) Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets α5β1 Integrin for the Treatment of both Sporadic and Familial ALS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tiago reis marquesGeorgea zimmermannLawrence steinmanPaulb manningOregon health sciences universityPasithea therapeutics corpNeurology department at stanford universityProceedings of the national academy sciencesChief executive officerMayo clinicNational academyEndowed chairNeurology departmentStanford university